Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Research-Grade Proteins Market Forecast Highlighting Growth From $1.61 Billion To $3.18 Billion
The research-grade proteins market has experienced an extremely rapid expansion over recent years. Its value is projected to rise from $1.33 billion in 2025 to $1.61 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.8%. This historic growth has been driven by several key factors, including the advancement of academic life sciences research, the growing application of proteins in molecular biology experiments, the expansion of biopharmaceutical research and development efforts, the increased availability of recombinant protein expression systems, and the influx of funding for fundamental biomedical research.
The market for research-grade proteins is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach a value of $3.19 billion by 2030, growing at a compound annual rate of 18.6%. This upward trajectory in the forecast period is largely driven by an intensified focus on precision medicine studies, a heightened demand for protein-derived drug targets, advancements in cellular and gene therapy investigations, a broader application of proteins within structural biology, and a growing trend among pharmaceutical companies to outsource their research activities. Key developments shaping this period include an increased requirement for highly purified proteins in drug discovery efforts, a rising utilization of recombinant proteins in both cellular and molecular biology analyses, a greater incorporation of research-grade proteins into immunology and oncology studies, a proliferation of protein-based assays and functional assessments, and a notable shift toward custom-designed and application-specific protein products.
Download A Free Sample Report For Comprehensive Market Insights:
Research-Grade Proteins Market Demand Drivers: What Is Fueling Industry Growth?
The expansion of the research-grade proteins market is being significantly driven by the increasing volume of clinical trials. These trials are studies designed to evaluate the safety and efficacy of new medical treatments, interventions, or devices in human subjects. A surge in their numbers has been observed, fueled by progress in medical research, a growing burden of diseases, shifts in regulatory frameworks, heightened patient demand, and substantial industry investments. Within this context, research-grade proteins play a critical role, providing essential support in biomarker development, assay creation, drug target identification, quality control, and as reference standards, all of which are vital for maintaining the precision and reliability of experimental findings. A notable example occurred in December 2024, when the Association of the British Pharmaceutical Industry (ABPI), based in the UK, reported that the number of new pharmaceutical industry trials in the UK grew for a second consecutive year, climbing from 411 in 2022 to 426 in 2023. Consequently, this upward trend in clinical trial activity is a key factor propelling the growth of the research-grade proteins market.
Research-Grade Proteins Market Segmentation And Category Breakdown
The research-grade proteins market covered in this report is segmented –
1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells
3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses
Subsegments:
1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor
2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies
3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens
5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases
6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers
7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline
8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins
Research-Grade Proteins Market Innovation Trends: Which Developments Are Transforming The Industry?
Key players in the research-grade proteins market are concentrating on creating advanced solutions like high-purity, animal-origin-free recombinant proteins, which aim to improve consistency, safety, and effectiveness in sophisticated cell and gene therapy processes. These proteins, manufactured synthetically in laboratories without any animal-derived components, are refined to exceptional standards to provide dependability and integrity for both scientific investigations and clinical uses. As an example, in October 2025, Qkine Ltd., a manufacturing firm based in the UK, introduced a novel series of Cell Therapy Grade recombinant proteins specifically crafted to meet the rigorous demands of cell therapy research, process optimization, and GMP production. These proteins, characterized by low endotoxin levels and minimal impurities from host cells, are created with standardized production protocols and comprehensive regulatory documentation. Their reliable performance facilitates seamless transition from early-stage research to GMP-compliant clinical applications. Tailored for complex uses such as CAR-T therapy, iPSC differentiation, and ex vivo gene editing, these regulation-compliant proteins accelerate therapy development while minimizing potential risks.
Research-Grade Proteins Market Competitive Analysis Of Major Industry Participants
Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)
Access The Complete Research-Grade Proteins Market Report:
Research-Grade Proteins Market Geographic Distribution And Regional Opportunities
North America was the largest region in the research-grade proteins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model